News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,319 Results
Type
Article (87997)
Company Profile (825)
Press Release (781478)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233274)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91427)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397946)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (627)
Autoimmune disease (163)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (666)
Cancer (5048)
Cardiovascular disease (444)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (37)
Clinical research (77041)
Collaboration (1823)
Company closure (5)
Compensation (1161)
Complete response letters (73)
COVID-19 (2992)
CRISPR (99)
C-suite (867)
Cystic fibrosis (154)
Data (6279)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7231)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (303)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100152)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135082)
Executive appointments (1033)
FDA (21581)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (215)
Generative AI (64)
Gene therapy (672)
GLP-1 (1130)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (61)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (99)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (855)
MASH (174)
Medical device (15028)
Medtech (15080)
Mergers & acquisitions (22989)
Metabolic disorders (1401)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (99)
Neuroscience (3118)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (677)
Opinion (336)
Ovarian cancer (167)
Pain (212)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (511)
Patient recruitment (483)
Peanut (60)
People (66919)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23802)
Phase 2 (33429)
Phase 3 (25195)
Pipeline (5092)
Policy (337)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (908)
Real estate (7440)
Recruiting (80)
Regulatory (29036)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1149)
Venture capital (96)
Weight loss (465)
Women's health (88)
Worklife (21)
Date
Today (101)
Last 7 days (516)
Last 30 days (2593)
Last 365 days (32894)
2026 (2630)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (90)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51568)
Australia (9058)
California (11559)
Canada (3315)
China (1171)
Colorado (488)
Connecticut (500)
Delaware (348)
Europe (118471)
Florida (1691)
Georgia (372)
Hawaii (4)
Idaho (68)
Illinois (965)
India (69)
Indiana (544)
Iowa (24)
Japan (430)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1457)
Massachusetts (8501)
Michigan (358)
Minnesota (666)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3111)
New Mexico (33)
New York (3051)
North Carolina (1611)
North Dakota (10)
Northern California (5528)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2312)
Puerto Rico (23)
Rhode Island (50)
South America (1662)
South Carolina (65)
South Dakota (1)
Southern California (4464)
Tennessee (177)
Texas (1825)
United States (41687)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (973)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,319 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Pfizer’s First Weight-Loss Data After Metsera Buy ‘Look Competitive’
With data from a mid-stage trial showing weight loss of up to 12.3% at 28 weeks in patients treated with PF’3944, “Pfizer is moving full speed into obesity clinical development,” BMO Capital Markets said Tuesday.
February 3, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC from Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
Deals
Roche Keeps The Deals Coming With Up To $1.7B SangeneBio RNAi Pact
The alliance will add to Roche’s RNAi efforts, which include the hypertension candidate zilbesiran, partnered with Alnylam under a July 2023 agreement.
February 3, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
February 3, 2026
·
7 min read
Layoff Tracker
GSK Puts Up to 350 US, UK Jobs on the Chopping Block
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
February 3, 2026
·
49 min read
·
BioSpace Editorial Staff
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy On Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Alzheon Reports Plasma Biomarker Results from Phase 3 and 2 Studies of Valiltramiprosate/ALZ-801, Validating Its First-in-Class Mechanism of Action and Underscoring Benefits in Cognition, Function, and Brain Volume Protection in Alzheimer’s Patients
February 3, 2026
·
12 min read
Press Releases
Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets
February 3, 2026
·
3 min read
Press Releases
RadNet Enters Indiana with Acquisition of Northwest Radiology
February 3, 2026
·
7 min read
Press Releases
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event
February 3, 2026
·
5 min read
1 of 87,032
Next
